Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tal Zaks, chief medical officer of Moderna, tells "Axios on HBO" that a COVID-19 vaccine could be available for children by the middle of next year.

Be smart: There will be a coronavirus vaccine for adults long before there is one for kids.

  • Moderna hasn't yet begun testing with anyone under 18 years-old, while Pfizer just recently began with teenagers.
  • Clinical trials for younger populations should move faster than did clinical trials for adults, because the vaccine-makers will begin with much more human data.
  • Zaks also warns not to "overinterpret the results" so far on efficacy, in that they only relate to protecting someone against getting sick, not against transmitting the virus to others.

The bottom line: Schools may not be able to fully reopen by late spring, even if all adult staff are vaccinated.

Go deeper

24 hours ago - Health

U.K. surpasses 100,000 COVID-19 deaths

Photo: Owen Humphreys/PA Images via Getty Images

The U.K. on Tuesday surpassed 100,000 coronavirus deaths almost a year after the first two cases were reported in the country, according to government figures.

Why it matters: It is the first European country and fifth country in the world to reach the threshold. The country reported 100,162 deaths on Tuesday.

Scammers have stolen over $130 million in coronavirus-related schemes

Photo: Chip Somodevilla/Getty Images

Over 100,000 Americans have collectively reported roughly $132 million in fraud losses from scams related to the coronavirus and government stimulus checks since the March start of the pandemic, according to the Federal Trade Commission.

Why it matters: Coronavirus-related fraud complaints peaked in May when the IRS began sending its first round of stimulus checks. Congress recently proposed a second round of stimulus.